NIH Awards Grant to SAB Biotherapeutics for Flu Treatment R&D
SAB Biotherapeutics has received a $1.42 million Small Business Innovation Research grant from the National Institutes of Health to fund the production and preclinical testing of an antibody the company designed to treat influenza. The company said Wednesday it teamed up with the University of South Dakota’s Sanford School of Medicine for the project under the BioSNTR program that works to […] More